FI91168B - Method for the production of human granulocyte-macrophage colony stimulating factor proteins - Google Patents

Method for the production of human granulocyte-macrophage colony stimulating factor proteins

Info

Publication number
FI91168B
FI91168B FI865186A FI865186A FI91168B FI 91168 B FI91168 B FI 91168B FI 865186 A FI865186 A FI 865186A FI 865186 A FI865186 A FI 865186A FI 91168 B FI91168 B FI 91168B
Authority
FI
Finland
Prior art keywords
stimulating factor
colony stimulating
macrophage colony
human granulocyte
production
Prior art date
Application number
FI865186A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI91168C (en
FI865186A0 (en
FI865186A (en
Inventor
Paul Habermann
Hubert Muellner
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of FI865186A0 publication Critical patent/FI865186A0/en
Publication of FI865186A publication Critical patent/FI865186A/en
Application granted granted Critical
Publication of FI91168B publication Critical patent/FI91168B/en
Publication of FI91168C publication Critical patent/FI91168C/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/55—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Wood Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

CSF proteins which are biologically active are obtained by expression of a gene coding for human granulocyte macrophage colony stimulating factor (CSF) in bacteria. Biologically active derivatives with a modified amino acid sequence are obtained by altering the natural or synthetic gene structure.
FI865186A 1985-12-21 1986-12-18 Process for Preparation of Human Granulocyte Macrophage Colony Stimulating Factor Proteins FI91168C (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19853545568 DE3545568A1 (en) 1985-12-21 1985-12-21 GM-CSF-PROTEIN, ITS DERIVATIVES, PRODUCTION OF SUCH PROTEINS AND THEIR USE

Publications (4)

Publication Number Publication Date
FI865186A0 FI865186A0 (en) 1986-12-18
FI865186A FI865186A (en) 1987-06-22
FI91168B true FI91168B (en) 1994-02-15
FI91168C FI91168C (en) 1994-05-25

Family

ID=6289242

Family Applications (1)

Application Number Title Priority Date Filing Date
FI865186A FI91168C (en) 1985-12-21 1986-12-18 Process for Preparation of Human Granulocyte Macrophage Colony Stimulating Factor Proteins

Country Status (17)

Country Link
EP (1) EP0228018B1 (en)
JP (1) JP2575367B2 (en)
KR (1) KR940005585B1 (en)
AT (1) ATE71144T1 (en)
AU (2) AU601959B2 (en)
CA (1) CA1341197C (en)
DE (2) DE3545568A1 (en)
DK (1) DK170346B1 (en)
ES (1) ES2055686T3 (en)
FI (1) FI91168C (en)
GR (1) GR3003999T3 (en)
HU (1) HU202584B (en)
IE (1) IE59779B1 (en)
IL (1) IL81020A (en)
NO (1) NO177270C (en)
PT (1) PT83972B (en)
ZA (1) ZA869557B (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5078996A (en) * 1985-08-16 1992-01-07 Immunex Corporation Activation of macrophage tumoricidal activity by granulocyte-macrophage colony stimulating factor
AU606585B2 (en) * 1985-10-03 1991-02-14 Biogen, Inc. Human granulocyte-macrophage colony stimulating factor-like polypeptides and processes for producing them in high yields in microbial cells
US5359035A (en) * 1985-12-21 1994-10-25 Hoechst Aktiengesellschaft Bifunctional proteins including interleukin-2 (IL-2) and granuloctyte macrophage colony stimulating factor (GM-CSF)
DE3712985A1 (en) * 1987-04-16 1988-11-03 Hoechst Ag BIFUNCTIONAL PROTEINS
JP2583770B2 (en) * 1986-09-17 1997-02-19 大塚製薬株式会社 gene
JPS6420097A (en) * 1987-03-02 1989-01-24 Sumitomo Chemical Co Human granulocyte-macrophage colony stimulating factor
AU609128B2 (en) * 1987-04-02 1991-04-26 Amrad Operations Pty. Limited Leukaemia-inhibitory factor
PT87133B (en) * 1987-04-02 1992-07-31 Amrad Corp Ltd METHOD OF PURIFICATION OF THE LEUKEMIA INHIBITOR FACTOR (LIF) AND PHARMACEUTICAL COMPOSITIONS CONTAINING POLIPEPTIDES WITH LIF ACTIVITY
EP0383764B1 (en) * 1987-06-25 1995-04-12 Immunex Corporation Bovine granulocyte-macrophage colony stimulating factor
EP0318184A1 (en) * 1987-11-12 1989-05-31 Schering Corporation Acceleration of bone formation with GM-CSF
GB2212159B (en) * 1987-11-13 1992-01-22 British Bio Technology Synthetic gene for human granulocyte/macrophage colony stimulating factor.
EP0413721A4 (en) * 1988-04-21 1991-11-13 Medvet Science Pty. Ltd. Human gm-csf variants
AU5355790A (en) * 1989-04-19 1990-11-16 Cetus Corporation Multifunctional m-csf proteins and genes encoding therefor
ATE103932T1 (en) * 1989-08-22 1994-04-15 Immunex Corp FUSION PROTEIN CONSISTING OF GM-CSF AND IL-3.
NZ236819A (en) * 1990-02-03 1993-07-27 Max Planck Gesellschaft Enzymatic cleavage of fusion proteins; fusion proteins; recombinant dna and pharmaceutical compositions
US5270181A (en) * 1991-02-06 1993-12-14 Genetics Institute, Inc. Peptide and protein fusions to thioredoxin and thioredoxin-like molecules
EP0872557A1 (en) * 1995-09-28 1998-10-21 Otsuka Pharmaceutical Co., Ltd. Neutrophil chemotactic lymphokine, and drug and kit for the diagnosis of drug hypersensitive granulocytopenia containing the same
KR100448021B1 (en) * 2001-12-28 2004-09-08 크레아젠 주식회사 Transgenic Escherichia coli transformed with pGM-CSF vector expressing recombinant mouse granulocyte-macrophage colony stimulating factor and method for mass production of the recombinant protein
SG188160A1 (en) * 2009-12-23 2013-03-28 Gradalis Inc Furin-knockdown and gm-csf-augmented (fang) cancer vaccine
SG181881A1 (en) 2009-12-23 2012-07-30 Gradalis Inc Furin-knockdown bi-functional rna

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4438032A (en) * 1981-01-30 1984-03-20 The Regents Of The University Of California Unique T-lymphocyte line and products derived therefrom
SE8300693L (en) * 1983-02-09 1984-08-10 Sven Lofdahl SET TO MAKE AND ISOLATE PROTEINS AND POLYPEPTIDES, AND A HYBRID VECTOR FOR THIS
IL71991A (en) * 1983-06-06 1994-05-30 Genentech Inc Preparation of mature human IGF and EGF via prokaryotic recombinant DNA technology
AU594014B2 (en) * 1984-03-21 1990-03-01 Research Corporation Technologies, Inc. Recombinant DNA molecules
ATE67244T1 (en) * 1984-07-06 1991-09-15 Sandoz Ag PRODUCTION AND PURIFICATION OF LYMPHOKINES.
ZA856108B (en) * 1984-10-29 1986-10-29 Immunex Corp Cloning of human granulocyte-macrophage colony simulating factor gene
AU588819B2 (en) * 1984-10-29 1989-09-28 Immunex Corporation Cloning of human granulocyte-macrophage colony stimulating factor gene
EP0202300B1 (en) * 1984-11-20 1992-11-11 Schering Biotech Corporation Cdna clones coding for polypeptides exhibiting human granulocyte macrophage and eosinophil cellular growth factor activity
AU606585B2 (en) * 1985-10-03 1991-02-14 Biogen, Inc. Human granulocyte-macrophage colony stimulating factor-like polypeptides and processes for producing them in high yields in microbial cells
DE3636903A1 (en) * 1985-12-21 1987-07-02 Hoechst Ag FUSION PROTEINS WITH EUKARYOTIC BALLASTES
DE3541856A1 (en) * 1985-11-27 1987-06-04 Hoechst Ag EUKARYOTIC FUSION PROTEINS, THEIR PRODUCTION AND USE, AND MEANS FOR CARRYING OUT THE PROCESS

Also Published As

Publication number Publication date
FI91168C (en) 1994-05-25
DE3683267D1 (en) 1992-02-13
ES2055686T3 (en) 1994-09-01
IL81020A (en) 1995-11-27
DK170346B1 (en) 1995-08-07
JP2575367B2 (en) 1997-01-22
NO865191L (en) 1987-06-22
KR940005585B1 (en) 1994-06-21
DK619086D0 (en) 1986-12-19
FI865186A0 (en) 1986-12-18
HU202584B (en) 1991-03-28
DK619086A (en) 1987-06-22
ZA869557B (en) 1987-10-28
IL81020A0 (en) 1987-03-31
AU601959B2 (en) 1990-09-27
KR870006188A (en) 1987-07-09
IE863335L (en) 1987-06-21
NO177270B (en) 1995-05-08
AU6675686A (en) 1987-06-25
GR3003999T3 (en) 1993-03-16
HUT44615A (en) 1988-03-28
IE59779B1 (en) 1994-04-06
CA1341197C (en) 2001-03-06
PT83972A (en) 1987-01-01
ATE71144T1 (en) 1992-01-15
AU6268390A (en) 1990-12-13
DE3545568A1 (en) 1987-07-16
JPS62164695A (en) 1987-07-21
EP0228018A2 (en) 1987-07-08
NO865191D0 (en) 1986-12-19
AU637139B2 (en) 1993-05-20
PT83972B (en) 1989-07-31
FI865186A (en) 1987-06-22
EP0228018A3 (en) 1987-12-02
NO177270C (en) 1995-08-16
EP0228018B1 (en) 1992-01-02

Similar Documents

Publication Publication Date Title
FI91168B (en) Method for the production of human granulocyte-macrophage colony stimulating factor proteins
ES2153444T3 (en) ANTIBODIES AGAINST INTERLEUCINE-4 MAMIFERA, AND USEFUL PEPTIDES AS ANTIGENS IN THEIR PRODUCTION.
FI864036A0 (en) A method for producing a mutein of a biologically active tumor necrosis factor protein
ATE112802T1 (en) PRODUCTION OF FUNCTIONAL HUMAN UROKINASEPOLYPEPTIDES.
DE3873397D1 (en) BIFUNCTIONAL PROTEINS.
ATE69241T1 (en) PRODUCTION OF POLYPEPTIDES WITH HUMAN GAMMA INTERFERON ACTIVITY.
DE3681144D1 (en) USE OF BIOLOGICALLY ACTIVE COPOLYMERS FOR THE PRODUCTION OF A MEDICINAL PRODUCT FOR STIMULATING THE GROWTH OF ANIMALS.
ATE71658T1 (en) PROCESS FOR PRODUCTION OF HUMAN LYSOZYME.
DE3777367D1 (en) HIRUDIN VARIANT, THEIR USE AND PRODUCTION.
JPS6480298A (en) Production of human proapolipoprotein a-i-like protein
BG45853A3 (en) Method for preparing of benzamide compounds
DE3853590D1 (en) CATTLE GRANULOCYT MACROPHAGE COLONY STIMULATING FACTOR.

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed
MM Patent lapsed

Owner name: HOECHST AKTIENGESELLSCHAFT